In order to investigate whether PTX can sensitise IGROV1 cells towards subsequent 177Lu-DOTA-chCE7 177Lu-DOTA-chCE7 177Lu-DOTA-chCE7 upon single or combined treatments was examined by MTT proliferation assays using previously determined Icell(10.0 ± 1.0 nM) and ½ IC50 (5 nM) of PTX as a basis for combination treatments.
These humidities were predicted successfully by a simplified dynamic adsorption model using previously determined equilibrium and rate data.
Diagnosis was determined by using previously taken x-rays or those taken onsite.
The crystal structure of the PSIPsaJF complex was solved by molecular replacement, first by using the previously determined cyanobacterial structure as a search model (PDB ID 1JBO) and later with a higher resolution model from Synechocystis (see 'Results' below).
On the contrary, in the "large-then-small" approach [Figure 6(b)], the large and shared unique shapes for V = V1 were determined first, by using the previously determined reference shapes for V = V1, and then the reference and basis shapes for V
Corrected counts were converted to μCi per milligram of tissue by using a previously determined counter efficiency.
For figure 2 and 3, PSI complexes isolated from Lhca depleted plants, PSI core and LHCI, concentration was adjusted to an equivalent number of PSI reaction centers, by using the previously determined mutants antenna sizes [ 34, 35].
The structure was solved by molecular replacement using the previously determined structure of the non-glycosylated form of Evasin-1.
The structure was solved by molecular replacement using the previously determined DCAF1-CtD structure, and a homology model constructed with the previously determined SIVsmm Vpx as template (PDB: 4CC9).
The structure was solved by molecular replacement using the previously determined structures of the ROCK-I kinase domain (Jacobs et al, 2006) and RhoE (Garavini et al, 2002) (Table I and Materials and methods).
